About Emily Savas

Emily Savas is a shareholder in Buchanan’s Chicago office. She brings a dynamic force to pharmaceutical IP litigation, guiding clients seamlessly from paragraph IV notices through trial and appeal with strategic precision. She specialises in defending and challenging patent claims on drug compounds, formulations and treatment methods across a broad spectrum of diseases. As a registered patent attorney with a molecular biology background, Emily’s expertise extends to patent prosecution, trade mark disputes and high-stakes contract negotiations – particularly in clinical research.